<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Vestibular neuritis and labyrinthitis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Vestibular neuritis and labyrinthitis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Vestibular neuritis and labyrinthitis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph M Furman, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael J Aminoff, MD, DSc
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel G Deschler, MD, FACS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Janet L Wilterdink, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 28, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vestibular neuritis is also known as vestibular neuronitis, labyrinthitis, neurolabyrinthitis, and acute peripheral vestibulopathy [
         <a href="#rid1">
          1
         </a>
         ]. A group of leading international experts has proposed the term "acute unilateral vestibulopathy" (AUVP) as the preferred name for this condition [
         <a href="#rid2">
          2
         </a>
         ]. It is a self-limited disorder, and most patients recover completely. Nonetheless, its symptoms of vertigo, nausea, vomiting, and gait impairment can be disabling in the short term.
        </p>
        <p>
         Vestibular neuritis also shares clinical features with less benign disorders, particularly acute vascular lesions of the central nervous system, from which it must be accurately differentiated in order to avoid morbidity and mortality.
        </p>
        <p>
         This topic will review the pathophysiology, clinical manifestations, diagnosis, and treatment of vestibular neuritis. The evaluation and differential diagnosis of vertigo are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">
          "Evaluation of the patient with vertigo"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">
          "Causes of vertigo"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vestibular neuritis is generally understood to be a viral or postviral inflammatory disorder affecting the vestibular portion of the eighth cranial nerve [
         <a href="#rid2">
          2
         </a>
         ]. There are few pathologic data to support this mechanism in patients with this disorder, and a history of a preceding viral illness is elicited in less than one-half of patients [
         <a href="#rid3">
          3-6
         </a>
         ]. One advanced magnetic resonance imaging (MRI) study revealed a pattern of enhancement consistent with an inflammatory process in 20 of 29 patients with vestibular neuritis [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vestibular neuritis, also known as vestibular neuronitis and labyrinthitis, represents an acute, spontaneous, peripheral vestibular ailment, characterized by the rapid onset of severe vertigo with nausea, vomiting, and gait instability.
        </p>
        <p>
         Physical examination findings are consistent with an acute vestibular imbalance  (
         <a class="graphic graphic_figure graphicRef139797" href="/z/d/graphic/139797.html" rel="external">
          figure 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spontaneous vestibular nystagmus that is unidirectional and horizontal or horizontal-torsional, is suppressed with visual fixation, and does not change direction with gaze. The fast phase of nystagmus beats away from the affected side.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Positive head impulse test. With rapid turning of the head toward the side of the lesion by the examiner, the patient is unable to maintain visual fixation  (
         <a class="graphic graphic_figure graphicRef52022" href="/z/d/graphic/52022.html" rel="external">
          figure 2
         </a>
         ). In one series, this was present in 82 percent of patients [
         <a href="#rid8">
          8
         </a>
         ]. Patients in this series with a positive head impulse sign were also more likely to have persistent symptoms. While a positive head impulse test supports the diagnosis of vestibular neuritis, it does not definitively rule out a central nervous system disorder [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">
          "Evaluation of the patient with vertigo", section on 'Other vestibular signs'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gait instability with preserved ability to ambulate. If the patient sways or falls, it is opposite to the direction of the fast component of the nystagmus, ie, toward the affected side.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other neurologic signs and symptoms (dysarthria, dysphagia, limb weakness, sensory loss, facial droop, limb dysmetria) are absent. Vertical diplopia or skew eye deviation may be present due to an imbalance in otolithic-ocular reflexes, although the presence of a significant vertical diplopia or skew deviation suggests that the patient has had a stroke. (See
         <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">
          "Evaluation of the patient with vertigo", section on 'Other vestibular signs'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Auditory function is preserved; when the symptoms and signs of vestibular neuritis are combined with unilateral hearing loss, the condition is called labyrinthitis.
        </p>
        <p>
        </p>
        <p>
         In one study of 101 patients, three clinical signs, in particular, were useful in distinguishing vestibular neuritis from a cerebrovascular event [
         <a href="#rid10">
          10
         </a>
         ]. The presence of either a normal head impulse test, direction changing nystagmus, or a skew deviation had a 100 percent sensitivity and a 96 percent specificity for stroke. These findings, codified as the HINTS examination (Head Impulse test, direction changing Nystagmus, Test of Skew), have been found to have a similarly high sensitivity and specificity for distinguishing peripheral from central vertigo in patients with an acute vestibular syndrome  (
         <a class="graphic graphic_figure graphicRef139797" href="/z/d/graphic/139797.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid11">
          11-15
         </a>
         ]. However, in all studies, examiners were either specialists or specifically trained in this examination.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many conditions cause vertigo  (
         <a class="graphic graphic_table graphicRef66539" href="/z/d/graphic/66539.html" rel="external">
          table 1
         </a>
         ). The clinical features of common causes of vertigo are summarized in the table  (
         <a class="graphic graphic_table graphicRef81596" href="/z/d/graphic/81596.html" rel="external">
          table 2
         </a>
         ). The differential diagnosis of vertigo is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">
          "Causes of vertigo"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">
          "Evaluation of the patient with vertigo"
         </a>
         .)
        </p>
        <p>
         The principal differential diagnostic concern in a patient presenting with acute sustained vertigo is a vascular event in the central nervous system affecting the cerebellum and/or brainstem [
         <a href="#rid16">
          16,17
         </a>
         ]. This possibility should be considered in all patients with vascular risk factors, because of the relatively high risk of recurrent vascular events [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Cerebellar hemorrhage or infarction
         </span>
         <span class="headingEndMark">
          —
         </span>
         An important consideration in the differential diagnosis of a patient with acute sustained vertigo is a vascular event (infarction or hemorrhage) in the cerebellum [
         <a href="#rid19">
          19,20
         </a>
         ]. As many as 25 percent of patients older than 50 years presenting to the emergency department with this clinical picture have a cerebellar infarction rather than vestibular neuritis, although the percentage is usually reported as much lower [
         <a href="#rid21">
          21-23
         </a>
         ]. As this alternative diagnosis represents a potentially immediately life-threatening condition, it is important to consider this possibility in every patient who presents with acute sustained vertigo. Patients with acute cerebellar lesions may have distinctive clinical features from that of vestibular neuritis  (
         <a class="graphic graphic_figure graphicRef139797" href="/z/d/graphic/139797.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid19">
          19,20,24
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The nystagmus is not suppressed with visual fixation. It may be other than horizontal or horizontal-torsional, and may change direction with gaze.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients are usually unable to stand or walk unsupported. The direction of falling is not necessarily opposite to the direction of the nystagmus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There may also be limb dysmetria, dysarthria, or headache.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Head impulse test is usually normal [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptoms may be unremitting for 72 hours or more.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with a vascular event are typically older and/or have atherosclerosis risk factors (hypertension, diabetes, smoking).
        </p>
        <p>
        </p>
        <p>
         Despite these caveats, the distinction between vestibular neuritis and acute cerebellar lesions is not always apparent; patients with acute vertigo are often quite ill, and the examination may be limited. When the diagnosis is unclear, a neuroimaging study, typically MRI, may be necessary [
         <a href="#rid4">
          4,20,25,26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Brainstem infarction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common stroke syndrome producing vertigo is a lateral medullary infarction producing a constellation of symptoms and signs known as a Wallenberg syndrome:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ipsilateral Horner syndrome
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dissociated sensory loss (loss of pain and temperature sensation on the ipsilateral face and contralateral limbs and trunk)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal eye movements
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ipsilateral loss of corneal reflex
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hoarseness and dysphagia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ipsilateral limb ataxia
        </p>
        <p>
        </p>
        <p>
         While these signs are usually apparent after a careful neurologic examination, these signs may be overlooked by patients and non-neurologists because the vertigo, nausea, and vomiting may overwhelm the clinical picture. In one study, more than half of patients with an acute vestibular syndrome subsequently found to be due to lateral medullary infarction did not have any of the above signs documented on clinical examination [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1102.html" rel="external">
          "Posterior circulation cerebrovascular syndromes", section on 'Lateral medullary infarction'
         </a>
         .)
        </p>
        <p>
         More restrictive brainstem infarctions have been described that affect isolated vestibular structures [
         <a href="#rid28">
          28
         </a>
         ]. Thus, their clinical manifestations are very similar to vestibular neuritis. While many of these infarcts are due to small arterial disease, and are managed by atherosclerosis risk factor management and antiplatelet therapy alone, some proportion (up to 50 percent in one series) has been found to be due to nonlacunar mechanisms (vertebral artery dissection or atrial fibrillation), suggesting that a high index of suspicion and accurate diagnosis is important [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A diagnosis of vestibular neuritis is largely based on the clinical presentation of an acute sustained vestibular syndrome with examination features consistent with a peripheral lesion as discussed above. There are no specific diagnostic tests.
        </p>
        <p>
         Neuroimaging is indicated to rule out alternative diagnoses if the examination is not entirely consistent with a peripheral lesion, if there are prominent risk factors for stroke, if there are focal neurologic signs or symptoms, or if there is a new headache accompanying the vertigo  (
         <a class="graphic graphic_figure graphicRef139797" href="/z/d/graphic/139797.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid4">
          4,29
         </a>
         ]. A younger patient with acute sustained vertigo, with no other neurologic signs or symptoms, and with nystagmus and an examination that is consistent with a peripheral origin (see
         <a class="local">
          'Clinical manifestations'
         </a>
         above) does not need imaging if there is improvement within 48 hours [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The procedure of choice is MRI with diffusion-weighted imaging (DWI) and angiography (MRA). MRI with DWI can detect infarction in the posterior fossa on the first day. MRA has a specificity and sensitivity exceeding 95 percent in detecting stenosis or occlusion of the posterior circulation [
         <a href="#rid30">
          30
         </a>
         ]. Small strokes in the brainstem or cerebellum may be missed on the initial MRI-DWI; thus, if the initial MRI is negative and the diagnosis of a central lesion is suspected, a repeat study should be ordered &gt;72 hours after the onset of symptoms with perfusion weighted sequences if available [
         <a href="#rid15">
          15,27
         </a>
         ].
        </p>
        <p>
         Computed tomography (CT) scanning with thin cuts through the cerebellum is an alternative when MRI scanning is not available or in patients with metallic implants. The scan is usually normal in the first hours after an infarct; however, intraparenchymal hemorrhage or significant edema compressing the fourth ventricle will usually be evident immediately. Thus, in patients who require brain imaging, a brain CT scan should therefore be performed if an MRI scan is not immediately available.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potential treatments for vestibular neuritis include acute disease-specific treatment with glucocorticoids and antiviral agents, symptomatic treatments, and vestibular rehabilitation. There are few formal studies of these therapies in patients with vestibular neuritis.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Acute disease-specific treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment with glucocorticoids during the acute period of vertigo was shown in at least one clinical trial to improve the recovery of peripheral vestibular function in patients with acute labyrinthitis. However, subsequent studies, albeit with many limitations, have not found a clear benefit of glucocorticoid therapy.
        </p>
        <p>
         Despite these somewhat conflicting results and remaining questions, it seems reasonable to treat presumed acute vestibular neuritis with glucocorticoid therapy if there are no contraindications. We typically prescribe a 10-day course of
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         ; 60 mg daily on days 1 through 5, 40 mg on day 6, 30 mg on day 7, 20 mg on day 8, 10 mg on day 9, and 5 mg on day 10. It is also reasonable not to treat with glucocorticoids in patients at risk for adverse effects.
        </p>
        <p>
         A controlled trial randomly assigned 141 patients with vestibular neuritis to one of four treatment groups:
         <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">
          methylprednisolone
         </a>
         ,
         <a class="drug drug_general" data-topicid="10034" href="/z/d/drug information/10034.html" rel="external">
          valacyclovir
         </a>
         , methylprednisolone plus valacyclovir, or placebo [
         <a href="#rid31">
          31
         </a>
         ]. The main outcome measure of vestibular function was the extent of unilateral caloric paresis; this was determined by measuring the mean peak slow-phase nystagmus velocity after caloric irrigation. The following observations were noted:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment with
         <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">
          methylprednisolone
         </a>
         (22-day tapering dose schedule) significantly improved vestibular function at 12-month follow-up compared with placebo.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment with
         <a class="drug drug_general" data-topicid="10034" href="/z/d/drug information/10034.html" rel="external">
          valacyclovir
         </a>
         1000 mg three times daily for seven days did not improve outcome.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment with the combination of
         <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">
          methylprednisolone
         </a>
         plus
         <a class="drug drug_general" data-topicid="10034" href="/z/d/drug information/10034.html" rel="external">
          valacyclovir
         </a>
         was no more effective than methylprednisolone alone.
        </p>
        <p>
        </p>
        <p>
         A meta-analysis examined the efficacy of glucocorticoids in four randomized controlled studies (149 patients) [
         <a href="#rid32">
          32
         </a>
         ]. There was an overall significant effect of glucocorticoid therapy on complete caloric recovery at 1 month but not at 12 months. Small sample size and methodologic issues with the included studies precluded firm conclusions regarding the benefit of glucocorticoids, particularly on long-term outcomes. Subsequent small trials with similar methodologic problems have also not shown a clear benefit of glucocorticoid therapy [
         <a href="#rid33">
          33-36
         </a>
         ], although observational studies continue to suggest a benefit, including one that showed that earlier treatment (within 24 versus 48 hours) was associated with a higher likelihood of normal caloric testing three months later [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Symptomatic treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Symptomatic treatments to reduce vertigo, nausea, and vomiting are often employed in the first few days of vestibular neuritis. These include antiemetics, antihistamines, anticholinergics, and benzodiazepines  (
         <a class="graphic graphic_table graphicRef68052" href="/z/d/graphic/68052.html" rel="external">
          table 3
         </a>
         ). A nonoral route is generally preferred. Lower doses should be attempted, with upward titration as needed. (See
         <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">
          "Treatment of vertigo", section on 'Symptomatic treatment'
         </a>
         .)
        </p>
        <p>
         There is little evidence supporting the use of one agent over another. In general, antihistamines and anticholinergics are preferred over benzodiazepines, because they are somewhat less sedating. One trial compared intravenous
         <a class="drug drug_general" data-topicid="8896" href="/z/d/drug information/8896.html" rel="external">
          dimenhydrinate
         </a>
         , 50 mg, with
         <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">
          lorazepam
         </a>
         , 2 mg, in 74 patients with acute peripheral vestibulopathy. After two hours, patients treated with dimenhydrinate had better ability to ambulate and were more likely to feel ready to go home compared with patients treated with lorazepam (86 versus 69 percent), who also felt drowsier after treatment [
         <a href="#rid39">
          39
         </a>
         ]. Another study compared intramuscular dimenhydrinate, 50 mg, with
         <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">
          droperidol
         </a>
         , 2.5 mg, in 40 patients with acute peripheral vertigo and found similar efficacy of the two agents; after 30 minutes, approximately 40 percent of patients felt sufficiently improved to go home without further treatment [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         While they provide necessary symptomatic relief in the first 24 to 48 hours, these medications are believed to be somewhat contraindicated after that time. By suppressing vestibular activity, they are believed to impair the central compensation response and delay long-term recovery.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Vestibular rehabilitation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vestibular exercises have been shown to be efficacious in improving symptoms and functioning as measured by a variety of symptom- and examination-based scores in patients with unilateral peripheral vestibular injury [
         <a href="#rid41">
          41
         </a>
         ]. In our clinical experience, these measured improvements are clinically meaningful. (See
         <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">
          "Treatment of vertigo", section on 'Vestibular rehabilitation'
         </a>
         .)
        </p>
        <p>
         Most studies of vestibular rehabilitation have not been specific to etiology. However, one study randomly assigned 39 patients with vestibular neuritis to physical therapy versus standard care [
         <a href="#rid42">
          42
         </a>
         ]. Evaluation at 30 days revealed that balance function was substantially improved in treated patients [
         <a href="#rid42">
          42
         </a>
         ]. Other measures of central compensation appeared similar between the groups.
        </p>
        <p>
         Vestibular rehabilitation is most likely to be efficacious when the patient is referred for a vestibular physical therapy evaluation and completes an individually designed program.
        </p>
        <p class="headingAnchor" id="H3595115706">
         <span class="h1">
          CLINICAL COURSE AND PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with vestibular neuritis generally suffer from severe vestibular symptoms for one to two days, followed by a gradual diminution of symptoms and a return of equilibrium. While the acute illness rarely lasts more than several days to a few weeks, residual imbalance and nonspecific dizziness may persist for months [
         <a href="#rid43">
          43
         </a>
         ]. Early improvement in symptoms is believed to be largely due to central compensation. Tests of vestibular function, such as caloric testing, often show improvement and ultimately recovery as well, but with a significant lag time compared with clinical symptoms.
        </p>
        <p>
         Recovery of responsiveness to vestibular stimulation including caloric stimulation and head impulse testing does not consistently correlate with long-term symptoms [
         <a href="#rid44">
          44
         </a>
         ]. Two studies have found that abnormal head impulse testing correlates with ongoing symptoms and predicts a more protracted course, especially if it remains positive in follow-up examinations [
         <a href="#rid45">
          45,46
         </a>
         ], whereas other studies found no correlation between abnormal head impulse testing and persistent dizziness [
         <a href="#rid44">
          44,47
         </a>
         ].
        </p>
        <p>
         Usually patients suffer from vestibular neuritis only once. In one case series of 103 patients followed for almost 10 years, just two patients had a recurrence, both in the contralateral ear [
         <a href="#rid48">
          48
         </a>
         ]. However, in one series, 15 percent of patients with vestibular neuritis later developed benign paroxysmal positional vertigo (BPPV) [
         <a href="#rid49">
          49
         </a>
         ]. Panic disorder has been found to develop in 10 percent of patients with vestibular neuritis over two years [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10131633">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15755.html" rel="external">
          "Patient education: Vertigo (a type of dizziness) (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83064.html" rel="external">
          "Patient education: Labyrinthitis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/721.html" rel="external">
          "Patient education: Vertigo (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – Vestibular neuritis is believed to be an acute viral or postviral inflammatory disorder of the vestibular portion of the eighth cranial nerve. (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Vestibular neuritis presents with acute onset of vertigo with nausea, vomiting, and gait impairment. In pure vestibular neuritis, auditory function is preserved; when this syndrome is combined with unilateral hearing loss, it is called labyrinthitis. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and differential diagnosis
         </strong>
         – The syndrome of acute-onset, sustained vertigo is not specific to vestibular neuritis but is also a presentation of vascular events in the cerebellum or brainstem. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Examination features can help distinguish these features; specifically, the presence of either a normal head impulse test  (
         <a class="graphic graphic_figure graphicRef52022" href="/z/d/graphic/52022.html" rel="external">
          figure 2
         </a>
         ), direction-changing nystagmus, or a skew deviation suggests that the diagnosis is likely a vascular event and mandates an urgent neuroimaging study (MRI). MRI should also be performed in patients with acute sustained vertigo who are older (&gt;60 years) or have headache, any focal neurologic signs, or vascular risk factors. There is no confirmatory test for vestibular neuritis. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – In patients with clinical features entirely consistent with vestibular neuritis and no contraindications to steroids, we suggest a glucocorticoid taper (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). While short-term recovery seems to be improved with this therapy, a benefit on long-term outcomes is uncertain. Thus, it is reasonable to choose not to treat patients with glucocorticoids, particularly if there are risk factors for adverse effects. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptomatic management
         </strong>
         – We suggest using vestibular suppressants and antiemetics to limit symptoms in the first 24 to 48 hours (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). We stop acute symptomatic treatments within 48 hours if the patient's symptoms allow, as some data suggest that these medications interfere with central compensation and long-term recovery. (See
         <a class="local">
          'Symptomatic treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of vestibular rehabilitation
         </strong>
         – We suggest early institution of a vestibular rehabilitation program after acute symptoms subside, as this may hasten long-term recovery, particularly of balance (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). (See
         <a class="local">
          'Treatment'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">
          "Treatment of vertigo"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Baloh RW. Clinical practice. Vestibular neuritis. N Engl J Med 2003; 348:1027.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strupp M, Bisdorff A, Furman J, et al. Acute unilateral vestibulopathy/vestibular neuritis: Diagnostic criteria. J Vestib Res 2022; 32:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rujescu D, Hartmann AM, Giegling I, et al. Genome-Wide Association Study in Vestibular Neuritis: Involvement of the Host Factor for HSV-1 Replication. Front Neurol 2018; 9:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hotson JR, Baloh RW. Acute vestibular syndrome. N Engl J Med 1998; 339:680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DIX MR, HALLPIKE CS. The pathology symptomatology and diagnosis of certain common disorders of the vestibular system. Proc R Soc Med 1952; 45:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silvoniemi P. Vestibular neuronitis. An otoneurological evaluation. Acta Otolaryngol Suppl 1988; 453:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Byun H, Chung JH, Lee SH, et al. Clinical value of 4-hour delayed gadolinium-Enhanced 3D FLAIR MR Images in Acute Vestibular Neuritis. Laryngoscope 2018; 128:1946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandalà M, Nuti D, Broman AT, Zee DS. Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis. Arch Otolaryngol Head Neck Surg 2008; 134:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newman-Toker DE, Kattah JC, Alvernia JE, Wang DZ. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology 2008; 70:2378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kattah JC, Talkad AV, Wang DZ, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 2009; 40:3504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen L, Lee W, Chambers BR, Dewey HM. Diagnostic accuracy of acute vestibular syndrome at the bedside in a stroke unit. J Neurol 2011; 258:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newman-Toker DE, Kerber KA, Hsieh YH, et al. HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness. Acad Emerg Med 2013; 20:986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newman-Toker DE, Saber Tehrani AS, Mantokoudis G, et al. Quantitative video-oculography to help diagnose stroke in acute vertigo and dizziness: toward an ECG for the eyes. Stroke 2013; 44:1158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohn B. Can bedside oculomotor (HINTS) testing differentiate central from peripheral causes of vertigo? Ann Emerg Med 2014; 64:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi JH, Park MG, Choi SY, et al. Acute Transient Vestibular Syndrome: Prevalence of Stroke and Efficacy of Bedside Evaluation. Stroke 2017; 48:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold DR, Reich SG. Clinical reasoning: a 55-year-old woman with vertigo. A dizzying conundrum. Neurology 2012; 79:e146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarnutzer AA, Berkowitz AL, Robinson KA, et al. Does my dizzy patient have a stroke? A systematic review of bedside diagnosis in acute vestibular syndrome. CMAJ 2011; 183:E571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee CC, Su YC, Ho HC, et al. Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study. Stroke 2011; 42:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee H, Sohn SI, Cho YW, et al. Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns. Neurology 2006; 67:1178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casani AP, Dallan I, Cerchiai N, et al. Cerebellar infarctions mimicking acute peripheral vertigo: how to avoid misdiagnosis? Otolaryngol Head Neck Surg 2013; 148:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norrving B, Magnusson M, Holtås S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand 1995; 91:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerber KA, Brown DL, Lisabeth LD, et al. Stroke among patients with dizziness, vertigo, and imbalance in the emergency department: a population-based study. Stroke 2006; 37:2484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerber KA, Zahuranec DB, Brown DL, et al. Stroke risk after nonstroke emergency department dizziness presentations: a population-based cohort study. Ann Neurol 2014; 75:899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee H, Kim HA. Nystagmus in SCA territory cerebellar infarction: pattern and a possible mechanism. J Neurol Neurosurg Psychiatry 2013; 84:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furman JM, Cass SP. Benign paroxysmal positional vertigo. N Engl J Med 1999; 341:1590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz NE, Venkat C, Albers GW. Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus. Arch Neurol 2007; 64:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saber Tehrani AS, Kattah JC, Mantokoudis G, et al. Small strokes causing severe vertigo: frequency of false-negative MRIs and nonlacunar mechanisms. Neurology 2014; 83:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JS. Vertigo and gait ataxia without usual signs of lateral medullary infarction: a clinical variant related to rostral-dorsolateral lesions. Cerebrovasc Dis 2000; 10:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee DH, Kim WY, Shim BS, et al. Characteristics of central lesions in patients with dizziness determined by diffusion MRI in the emergency department. Emerg Med J 2014; 31:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Becker KJ, Purcell LL, Hacke W, Hanley DF. Vertebrobasilar thrombosis: diagnosis, management, and the use of intra-arterial thrombolytics. Crit Care Med 1996; 24:1729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fishman JM, Burgess C, Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev 2011; :CD008607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goudakos JK, Markou KD, Psillas G, et al. Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2014; 140:434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adamec I, Krbot Skorić M, Gabelić T, et al. Intravenous dexamethasone in acute management of vestibular neuritis: a randomized, placebo-controlled, single-blind trial. Eur J Emerg Med 2016; 23:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JC, Cha WW, Chang DS, Lee HY. The Effect of Intravenous Dexamethasone on the Nausea Accompanying Vestibular Neuritis: A Preliminary Study. Clin Ther 2015; 37:2536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoo MH, Yang CJ, Kim SA, et al. Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial. Eur Arch Otorhinolaryngol 2017; 274:2443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batuecas-Caletrío A, Yañez-Gonzalez R, Sanchez-Blanco C, et al. Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy. J Neurol 2015; 262:2578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sjögren J, Magnusson M, Tjernström F, Karlberg M. Steroids for Acute Vestibular Neuronitis-the Earlier the Treatment, the Better the Outcome? Otol Neurotol 2019; 40:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marill KA, Walsh MJ, Nelson BK. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Ann Emerg Med 2000; 36:310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irving C, Richman P, Kaiafas C, et al. Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial. Acad Emerg Med 2002; 9:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2015; 1:CD005397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strupp M, Arbusow V, Maag KP, et al. Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis. Neurology 1998; 51:838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bronstein AM, Dieterich M. Long-term clinical outcome in vestibular neuritis. Curr Opin Neurol 2019; 32:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel M, Arshad Q, Roberts RE, et al. Chronic Symptoms After Vestibular Neuritis and the High-Velocity Vestibulo-Ocular Reflex. Otol Neurotol 2016; 37:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HA, Hong JH, Lee H, et al. Otolith dysfunction in vestibular neuritis: recovery pattern and a predictor of symptom recovery. Neurology 2008; 70:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nuti D, Mandalà M, Broman AT, Zee DS. Acute vestibular neuritis: prognosis based upon bedside clinical tests (thrusts and heaves). Ann N Y Acad Sci 2005; 1039:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palla A, Straumann D, Bronstein AM. Vestibular neuritis: vertigo and the high-acceleration vestibulo-ocular reflex. J Neurol 2008; 255:1479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huppert D, Strupp M, Theil D, et al. Low recurrence rate of vestibular neuritis: a long-term follow-up. Neurology 2006; 67:1870.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic features in 240 cases. Neurology 1987; 37:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Godemann F, Schuller J, Uhlemann H, et al. Psychodynamic vulnerability factors in the development of panic disorders--a prospective trial in patients after vestibular neuritis. Psychopathology 2009; 42:99.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5102 Version 12.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12637613" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Clinical practice. Vestibular neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35723133" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Acute unilateral vestibulopathy/vestibular neuritis: Diagnostic criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30079052" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Genome-Wide Association Study in Vestibular Neuritis: Involvement of the Host Factor for HSV-1 Replication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9725927" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Acute vestibular syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14941845" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The pathology symptomatology and diagnosis of certain common disorders of the vestibular system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3068952" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Vestibular neuronitis. An otoneurological evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29330961" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Clinical value of 4-hour delayed gadolinium-Enhanced 3D FLAIR MR Images in Acute Vestibular Neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18283159" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18541870" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19762709" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21153732" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Diagnostic accuracy of acute vestibular syndrome at the bedside in a stroke unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24127701" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23463752" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Quantitative video-oculography to help diagnose stroke in acute vertigo and dizziness: toward an ECG for the eyes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24530107" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Can bedside oculomotor (HINTS) testing differentiate central from peripheral causes of vertigo?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28100765" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Acute Transient Vestibular Syndrome: Prevalence of Stroke and Efficacy of Bedside Evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23091079" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Clinical reasoning: a 55-year-old woman with vertigo. A dizzying conundrum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21576300" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Does my dizzy patient have a stroke? A systematic review of bedside diagnosis in acute vestibular syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21127296" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17030749" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23307911" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Cerebellar infarctions mimicking acute peripheral vertigo: how to avoid misdiagnosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7732773" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Isolated acute vertigo in the elderly; vestibular or vascular disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16946161" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Stroke among patients with dizziness, vertigo, and imbalance in the emergency department: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24788511" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Stroke risk after nonstroke emergency department dizziness presentations: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23172866" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Nystagmus in SCA territory cerebellar infarction: pattern and a possible mechanism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10564690" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Benign paroxysmal positional vertigo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17562941" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24920847" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Small strokes causing severe vertigo: frequency of false-negative MRIs and nonlacunar mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11070379" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Vertigo and gait ataxia without usual signs of lateral medullary infarction: a clinical variant related to rostral-dorsolateral lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23722117" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Characteristics of central lesions in patients with dizziness determined by diffusion MRI in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8874314" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Vertebrobasilar thrombosis: diagnosis, management, and the use of intra-arterial thrombolytics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15269315" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21563170" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24604142" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25919484" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Intravenous dexamethasone in acute management of vestibular neuritis: a randomized, placebo-controlled, single-blind trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26475420" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The Effect of Intravenous Dexamethasone on the Nausea Accompanying Vestibular Neuritis: A Preliminary Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28391531" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26459091" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30681432" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Steroids for Acute Vestibular Neuronitis-the Earlier the Treatment, the Better the Outcome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11020677" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12045085" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25581507" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9748036" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30566414" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Long-term clinical outcome in vestibular neuritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26719963" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Chronic Symptoms After Vestibular Neuritis and the High-Velocity Vestibulo-Ocular Reflex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18250289" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Otolith dysfunction in vestibular neuritis: recovery pattern and a predictor of symptom recovery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15826989" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Acute vestibular neuritis: prognosis based upon bedside clinical tests (thrusts and heaves).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18604466" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Vestibular neuritis: vertigo and the high-acceleration vestibulo-ocular reflex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17130428" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Low recurrence rate of vestibular neuritis: a long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3822129" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Benign positional vertigo: clinical and oculographic features in 240 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19225244" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Psychodynamic vulnerability factors in the development of panic disorders--a prospective trial in patients after vestibular neuritis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
